Post Marketing Study

The Study of Nanotherm Therapy Is Launched by Magforce After Entering German Marketing
Apr 11, 2013
MagForce has obtained German Federal Institute for Drugs and Medical Devices' (BfArM) approval for the start of a post-marketing clinical study in recurrent glioblastoma patients. The controlled, open-label and randomized study will ...

Tags: Magforce, Post-Marketing Study, Nanotherm Therapy